Immunization News and Research

RSS

Vaccine-induced cellular immune responses against HIV-1 infection exert selective pressure on the virus

An AIDS vaccine tested in people, but found to be ineffective, influenced the genetic makeup of the virus that slipped past. The findings suggest new ideas for developing HIV vaccines.

2 Mar 2011

Axolotl's two EHR systems receive ONC-ATCB certification

Axolotl Corp. announced that two of its electronic health record systems - Axolotl EHR, version 7 and Elysium EMR Lite - have received Office of the National Coordinator for Health IT Authorized Testing and Certification Body 2011/2012 certifications in accordance with Eligible Provider certification criteria adopted by the U.S. Department of Health and Human Services.

1 Mar 2011

AHRQ: High levels of disparities prevail, despite improvements in health care quality

Improvements in health care quality continue to progress at a slow rate - about 2.3 percent a year; however, disparities based on race and ethnicity, socioeconomic status and other factors persist at unacceptably high levels, according to the 2010 National Healthcare Quality Report and National Healthcare Disparities Report issued today by HHS' Agency for Healthcare Research and Quality.

1 Mar 2011

Intercell reports EUR 255.2m net loss for full year 2010

Today Intercell AG announced its financial results for Q4 and the preliminary results for the full financial year 2010 and presented an update on the Company's development programs.

1 Mar 2011

CellSeed, LA BioMed enter two-year research agreement to study core technology in regenerative medicine

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and CellSeed Inc., a Japanese biotechnology firm, have entered into a two-year research agreement to study CellSeed's proprietary core technology in regenerative medicine, "Cell Sheet Engineering," LA BioMed President and CEO David I. Meyer, PhD, announced today.

28 Feb 2011

Vaccine lawsuit rejected by Supreme Court

The U.S. Supreme Court ruled on Tuesday against the parents of Hannah Bruesewitz, 18, who suffered seizures and permanent brain damage after receiving a diptheria-tetanus-pertussis (DTP) vaccine in 1993. The Bruesewitz family had sued Wyeth who was then the parent company of the maker of the DTP vaccine that Hannah received as an infant.

27 Feb 2011

Mass polio vaccination campaigns in Burma and Sudan

After a seven-month-old baby was diagnosed with polio, Myanmar is planning a mass polio vaccination said the United Nations Children’s Fund. UNICEF revealed that just one case is enough to trigger an “emergency response”, and health officials promptly vaccinated 10,000 children in the Mandalay region, central Myanmar, after the illness was first suspected in December 2010.

23 Feb 2011

Kaiser Permanente leads nation in number of Stage 7 Awards from HIMSS

Kaiser Permanente, the nation's leading health care provider and not-for-profit health plan, continues to lead the nation in the number of Stage 7 Awards from the Healthcare Information and Management Systems Society. The Stage 7 Award honors hospitals that have achieved the highest level of electronic health record implementation. In the last three years, Kaiser Permanente has now received a total of 35 awards in recognition of its health information technology expertise.

23 Feb 2011

GE Healthcare IT introduces eHealth Community Desktop solution

GE Healthcare IT, a leading provider of health information technologies, today announced its eHealth Community Desktop, an open standards framework for delivering clinical applications built on top of a connected healthcare community. Its foundation is a portal technology that provides Clinicians and other providers across the healthcare continuum a web-based, simple and easy way to view patient data available within a Health Information Exchange (HIE).

23 Feb 2011

New nanoparticle can help develop vaccines against HIV, malaria

MIT engineers have designed a new type of nanoparticle that could safely and effectively deliver vaccines for diseases such as HIV and malaria.

23 Feb 2011

Novartis FLUAD seasonal flu vaccine for older adults receives Health Canada approval

Health Canada has approved FLUAD, a Novartis seasonal flu vaccine for adults 65 years and older. Canadian seniors are the hardest hit of all age groups by seasonal influenza and account for 90 per cent of influenza deaths and 70 per cent of hospitalizations.

22 Feb 2011

Xerox helps healthcare clients with technology and consulting services to improve quality of care

A growing number of healthcare organizations are turning to Xerox Corporation for technology and consulting services in support of Electronic Health Records. In the past year, more than 50 clients hired Xerox to advise them on everything from securing meaningful use funding to building Health Information Exchanges.

22 Feb 2011

Sanofi Pasteur, International Vaccine Institute support Dengue Vaccine Initiative

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it is partnering with the International Vaccine Institute (IVI) to support the recently launched Dengue Vaccine Initiative (DVI). Sanofi Pasteur and the IVI will aim to raise awareness and to work to move dengue vaccination higher on the global health agenda.

21 Feb 2011

Bangladesh cholera vaccine trial

Bangladesh will conduct the world’s largest clinical trial of an affordable cholera vaccine which could save tens of thousands of lives. The study began Thursday and involves nearly 250,000 people near the capital, Dhaka.

20 Feb 2011

Recent releases in Global Health

Factors Contributing to Health Of Women Worldwide: The Kaiser Family Foundation features a narrated slide tutorial by epidemiologist Laurel Spielberg on the health issues facing women around the world. The tutorial touches on issues such as economic status and biological, social, and cultural factors that affect women's health, as well as access to health services such as family planning (2/17).

19 Feb 2011

Brain enzyme blocks accumulation of tau proteins, slows down progression of neural degeneration

Increasing puromycin-sensitive aminopeptidase, the most abundant brain peptidase in mammals, slowed the damaging accumulation of tau proteins that are toxic to nerve cells and eventually lead to the neurofibrillary tangles, a major pathological hallmark of Alzheimer's disease and other forms of dementia, according to a study published online in the journal, Human Molecular Genetics.

17 Feb 2011

HHS unveils new National Vaccine Plan to enhance coordination of immunization activities

The U.S. Department of Health and Human Services today unveiled a new National Vaccine Plan to enhance coordination of all aspects of federal vaccine and immunization activities. Its goal is to ensure that all Americans can access the preventive benefits of vaccines.

17 Feb 2011

Flu vaccine update

This new vaccine which could become available in the United States in the next few years, is made by growing the influenza virus in cultures of animal cells rather than in the chicken eggs that have been used for more than five decades. This shortens the process by six months. Using animal cells, which are grown in enclosed steel tanks, also reduces the risk of bacterial contamination, which has led to shortages of seasonal vaccines in some years. The study was reported in The Lancet this Tuesday.

16 Feb 2011

Microsoft, Visionshare partner to enhance health information transaction between physicians, patients

VisionShare, the nation's largest and most trusted healthcare information network, announced today that it is working with Microsoft Corp. to enhance the transaction of health information from physicians to their patients based on security protocols endorsed by the Office of the National Coordinator's Direct Project.

16 Feb 2011

GAVI chair calls for greater reductions in vaccine prices for developing countries

On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).

16 Feb 2011

Immunization News and Research

Vaccine-induced cellular immune responses against HIV-1 infection exert selective pressure on the virus

Axolotl's two EHR systems receive ONC-ATCB certification

AHRQ: High levels of disparities prevail, despite improvements in health care quality

Intercell reports EUR 255.2m net loss for full year 2010

CellSeed, LA BioMed enter two-year research agreement to study core technology in regenerative medicine

Vaccine lawsuit rejected by Supreme Court

Mass polio vaccination campaigns in Burma and Sudan

Kaiser Permanente leads nation in number of Stage 7 Awards from HIMSS

GE Healthcare IT introduces eHealth Community Desktop solution

New nanoparticle can help develop vaccines against HIV, malaria

Novartis FLUAD seasonal flu vaccine for older adults receives Health Canada approval

Xerox helps healthcare clients with technology and consulting services to improve quality of care

Sanofi Pasteur, International Vaccine Institute support Dengue Vaccine Initiative

Bangladesh cholera vaccine trial

Recent releases in Global Health

Brain enzyme blocks accumulation of tau proteins, slows down progression of neural degeneration

HHS unveils new National Vaccine Plan to enhance coordination of immunization activities

Flu vaccine update

Microsoft, Visionshare partner to enhance health information transaction between physicians, patients

GAVI chair calls for greater reductions in vaccine prices for developing countries

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News